The forecasted HIV-AIDS mortality rate in the US remains stable at 1.5 deaths per 100,000 persons from 2024 to 2028, indicating no year-on-year variation. In 2023, the rate equaled 1.5, so over the two-year outlook, there is no percentage change. With a stable value across the five-year forecast period, the compound annual growth rate (CAGR) is 0%.
Future trends to watch include advances in HIV-AIDS treatment and prevention measures that could drive mortality rates lower. Public health policy and the introduction of new therapies may also impact these forecast figures, emphasizing the importance of monitoring healthcare innovations and policy changes.
